ProQR Therapeutics N.V (NASDAQ:PRQR) currently has a daily average trading volume of 129.38K but it saw 52037396 shares traded in last market. With a market cap of 328.35M USD, the company’s current market price of $4.02 came rising about 122.10 while comparing to the previous closing price of $1.81. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.29 and as low as $1.11. In the recent trading on the day, stock has struck highest price mark of $2.04 while lowest mark touched by it was $4.13.
Taking a look at 20-day trading activity of ProQR Therapeutics N.V (PRQR) gives us an average price of $1.9300, while its current price level is 22.19% below from 52-week high level whereas it is 262.16% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.9600 while that of 200 days or SMA-200 reads an average of $1.9900. A closer look into the stock’s movement over the week reveals that its volatility is standing at 24.68% during that period while stretching the period over a month that decreases to 12.16%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 90.00 which implies that the stock is in overbought territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Chardan Capital Markets which upgraded the stock as “Buy” in its note to investors issued on November 08, 2023, recommending a price target of $2 for it. JMP Securities upgraded its recommendation for the stock as a “Mkt Outperform” from “Mkt Perform” on March 30, 2023 while assigning a price target range of $1.50-$5. Cantor Fitzgerald also issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $0.80 and $5.
Over the week, PRQR’s stock price is moving 114.97% up while it is 119.67% when we observe its performance for the past one month. Year-to-date it is 103.03% up and over the past year, the stock is showing an upside performance of 209.23%.
Currently, ProQR Therapeutics N.V’s total number of outstanding shares is 78.46M. Company’s return on investment (ROI) stands at -47.37% and return on equity (ROE) at -50.85%. Stock’s beta reads 0.38. Stock has a price to book (P/B) ratio of 9.33 while price to sale or P/S ratio amounts to 19.73. Its return on asset (ROA) is -16.19% on average.
